MyAverix Finance
HK · Healthcare
Mabpharm Ltd (2181)
Biotechnology
Mabpharm Ltd (2181) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $1.81B, P/E ratio is 44.00, net margin is 8.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2181
Mabpharm Ltd (2181) — FAQ
What is Mabpharm Ltd's market cap?
Mabpharm Ltd (2181) has a reported market cap of $1.81B (data as of 2026-05-21).
What is 2181's P/E ratio?
The price-to-earnings (P/E) ratio for Mabpharm Ltd (2181) is 44.00 (data as of 2026-05-21).
Does Mabpharm Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Mabpharm Ltd (2181). Check the MyAverix Finance app for the latest dividend data.
What sector is Mabpharm Ltd in?
Mabpharm Ltd (2181) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2181 listed on?
2181 is listed on HK.
What is Mabpharm Ltd's net margin?
Mabpharm Ltd (2181) reports a net margin of 8.8% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.